mitozolomide has been researched along with Bladder Cancer in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Margison, GP; Masters, JR; Walker, MC | 1 |
| Blackledge, G; de Stavola, B; Kaye, S; Roberts, JT; Taylor, R; Uscinska, B; Williams, J | 1 |
2 other study(ies) available for mitozolomide and Bladder Cancer
| Article | Year |
|---|---|
O6-alkylguanine-DNA-alkyltransferase activity and nitrosourea sensitivity in human cancer cell lines.
Topics: Antineoplastic Agents; Cisplatin; Drug Resistance; Drug Screening Assays, Antitumor; Humans; Male; Methylnitrosourea; Methyltransferases; Nitrogen Mustard Compounds; O(6)-Methylguanine-DNA Methyltransferase; Testicular Neoplasms; Tumor Cells, Cultured; Urinary Bladder Neoplasms | 1992 |
A phase II study of mitozolomide in metastatic transitional cell carcinoma of the bladder.
Topics: Aged; Aged, 80 and over; Antineoplastic Agents; Carcinoma, Transitional Cell; Drug Evaluation; Female; Humans; Leukopenia; Male; Middle Aged; Nitrogen Mustard Compounds; Thrombocytopenia; Urinary Bladder Neoplasms | 1989 |